Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results
Go back to Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results| (NYSE: CLDI) | Delayed: 1.59 +0.05 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.54 | 52 Week High | $ | |||
| Open | $1.50 | 52 Week Low | $ | |||
| Day High | $1.63 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $ | |||
| Volume | 155,664 | |||||
